Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

It’s hard to imagine, but six concertos written in hopes of a job have become Johann Sebastian Bach’s most popular music.

Scroll through artwork by the teenage winners of our Coming of Age in 2024 contest. Then, tell us how well the collection captures your feelings and experiences. By Katherine Schulten When ...